Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity

Yuval Shaked, Urban Emmenegger, Shan Man, Dave Cervi, Francesco Bertolini, Yaacov Ben-David, Robert S. Kerbel

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences